Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
As of April 2025 Novartis has a market cap of C$302.55 Billion. This makes Novartis the world's 53th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$302.55 B | 7.18% |
2024 | C$282.27 B | 2.54% |
2023 | C$275.27 B | 3.96% |
2022 | C$264.79 B | 5.75% |
2021 | C$250.38 B | -9.83% |
2020 | C$277.67 B | -1.04% |
2019 | C$280.58 B | 4.41% |
2018 | C$268.73 B | 8.4% |
2017 | C$247.91 B | 6.64% |
2016 | C$232.46 B | -19.61% |
2015 | C$289.18 B | 11.24% |
2014 | C$259.96 B | 25.47% |
2013 | C$207.19 B | 36.78% |
2012 | C$151.47 B | 7.84% |
2011 | C$140.46 B | 4.41% |
2010 | C$134.53 B | 2.26% |
2009 | C$131.56 B | -3.99% |
2008 | C$137.02 B | 11.69% |
2007 | C$122.68 B | -21.88% |
2006 | C$157.04 B | 10.03% |
2005 | C$142.72 B | -3.12% |
2004 | C$147.31 B | 0.28% |
2003 | C$146.90 B | 2.32% |
2002 | C$143.57 B | -3.1% |
2001 | C$148.16 B | -15.22% |
2000 | C$174.76 B | 26.05% |
1999 | C$138.64 B | -32.81% |
1998 | C$206.36 B |
On Apr 15th, 2025 the market cap of Novartis was reported to be: